Rheumatology

Guidelines (9)

Certolizumab Pegol for Treating Rheumatoid Arthritis after Inadequate Response to a TNF-Alpha Inhibitor (TA415)

26 October 2016

Care and Management of Osteoarthritis in Adults (NICE Guideline)

15 March 2014

Summary of NICE guidance on OA assessment and treatment.

Pegloticase for Treating Severe Debilitating Chronic Tophaceous Gout (TA291)

26 June 2013

Abatacept for Treating Rheumatoid Arthritis After the Failure of Conventional Disease-Modifying Anti-Rheumatic Drugs (TA280)

24 April 2013

Denosumab for the Treatment of Therapy-Induced Bone Loss in Non-Metastatic Prostate Cancer (terminated appraisal) (TA194)

24 January 2013

Denosumab for the Prevention of Skeletal-Related Events in Adults with Bone Metastases from Solid Tumours (TA265)

24 October 2012

Tocilizumab for the Treatment of Rheumatoid Arthritis (TA247)

26 March 2012

Denosumab for the Prevention of Osteoporotic Fractures in Postmenopausal Women (TA204)

31 October 2010

Febuxostat for the Management of Hyperuricaemia in People with Gout (TA164)

14 April 2010

Tables (2)

Table: Vitamin D3 Supplements

18 July 2019

Formulations and indications of colecalciferol preparations.

Table: Calcium and Vitamin D Supplements for Osteoporosis

8 July 2019

Formulations, doses and costs of osteoporosis supplements.

Drug Sections (6)

Rheumatology in the News

Compare vitamin D supplements with new MIMS table

By Chloe Harman, 8 July 2019

MIMS has published a new table summarising key information...

Calcium and Vitamin D Supplements for Osteoporosis